Repare Therapeutics Inc.

NASDAQ:RPTX

1.66 (USD) • At close August 28, 2025
Overzicht | Financiële gegevens

Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) USD.

2025 Q22025 Q12024 Q42024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q1
Omzet 0.250053.4771.07352.40413.0472.15930.2495.67818.198112.5450.6790.4086.8770.2780.2790.1660.1350000000
Kosten van de omzet 01.18678.068-0.0570.4880.5010.50610.71.0510.9821.01831.2421.0726.4580.99325.36120.20516.50911.10110.0918.9518.63220.275000
Brutowinst 0.25-1.186-0.45440.0990.58551.90312.541-8.54129.1984.69617.1881.303-0.391-26.055.884-25.083-19.926-16.343-10.966-10.091-8.951-8.632-20.275000
Brutowinstmarge 1000.750.5450.990.961-3.9560.9650.8270.9440.722-0.576-63.8480.856-90.227-71.419-98.452-81.230000000
Onderzoek- en ontwikkelingskosten 14.28320.2725.74428.40129.32732.46934.4632.70933.78831.8329.89131.24231.47526.45827.97225.36120.20516.50912.41710.0918.9518.6326.8215.6184.8533.703
Algemene en administratieve kosten 6.0297.6526.3016.4448.3178.6188.6487.8688.7198.5297.9397.9047.9388.7797.6396.5966.7415.2374.7923.9963.3722.1832.0241.251.0321.076
Verkoop- en marketingkosten 000000-0.1160000000000000000000
Verkoop-, algemene en administratieve kosten 6.0297.6526.3016.4448.3178.6188.5327.8688.7198.5297.9397.9047.9388.7797.6396.5966.7415.2374.7923.9963.3722.1832.0241.251.0321.076
Overige kosten -2.2823.265-79.4651.527000-32.709-0.026-0.0150.013-0.037-0.011-0.008-0.02-0.007-0.007-0.007-0.006-0.004-0.004-0.002-0.01400-0.022
Bedrijfskosten 18.0331.187-47.4236.37237.64441.08742.9927.86842.50740.35937.8339.14639.41335.23735.61131.95726.94621.74617.20914.08712.32310.8158.8456.8685.8854.779
Bedrijfsresultaat -17.78-31.187-30.656-36.372-37.31910.816-30.451-38.418-12.258-34.681-19.63273.399-38.734-34.829-28.734-31.679-26.667-21.58-17.074-14.087-12.323-10.815-8.845-6.868-5.885-4.779
Bedrijfsresultaat ratio -71.1200-0.68-34.780.206-2.334-17.794-0.405-6.108-1.0790.652-57.046-85.365-4.178-113.953-95.581-130-126.4740000000
Totaal overige inkomsten en kosten netto 1.2841.5141.9772.4512.8712.9753.0273.243.4223.3563.0022.1160.6740.1040.0320.079-0.0630.0260.260.4420.591-1.7330.551-0.791-0.4540.05
Inkomen voor belasting -16.496-29.673-28.531-33.921-34.18813.791-27.424-35.178-8.836-31.325-16.6375.515-38.06-34.725-28.702-31.6-26.73-21.554-16.815-13.645-11.732-12.548-8.294-7.659-6.339-4.729
Inkomen voor belasting ratio -65.98400-0.634-31.8620.263-2.102-16.294-0.292-5.517-0.9140.671-56.053-85.11-4.174-113.669-95.806-129.843-124.5560000000
Belastingkosten 0.248-0.370.140.4850.5860.6290.606-16.2993.113.61615.0280.0540.0330.032-0.412-0.708-0.421-0.137-1.5540.1060.070.0530.0370.0290.020.109
Nettowinst -16.744-30.043-28.671-34.406-34.77413.162-28.03-18.879-11.946-34.941-31.65875.461-38.093-34.757-28.29-30.892-26.309-21.417-15.261-13.751-11.802-12.601-8.331-7.688-6.359-4.838
Nettowinstmarge -66.97600-0.643-32.4080.251-2.148-8.744-0.395-6.154-1.740.67-56.102-85.189-4.114-111.122-94.297-129.018-113.0440000000
WPA (Winst Per Aandeel) -0.39-0.71-0.67-0.81-0.820.31-0.67-0.45-0.28-0.83-0.751.8-0.91-0.83-0.71-0.83-0.71-0.58-0.41-0.37-2.45-0.4-0.36-0.33-0.27-0.21
Verwaterde WPA -0.39-0.71-0.67-0.81-0.820.3-0.67-0.45-0.28-0.83-0.751.71-0.91-0.83-0.7-0.83-0.71-0.58-0.41-0.37-2.45-0.4-0.36-0.33-0.27-0.21
EBITDA -19.026-31.187-28.077-34.367-36.81811.317-30.361-37.92-11.752-34.24-19.17773.883-38.211-34.313-28.366-31.31-26.255-21.258-16.79-13.88-12.116-10.619-8.656-6.714-5.745-4.657
EBITDA ratio -76.10400-0.643-34.3130.216-2.327-17.564-0.389-6.03-1.0540.656-56.275-84.1-4.125-112.626-94.104-128.06-124.370000000